These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9139021)

  • 21. [Post-arteriographic thrombosis of the ophthalmic veins in 2 cases of peripheral neuropathy with central neurological signs due to perhexiline maleate].
    Poisson M; Tempier P; Sichez JP; Mashaly R
    Nouv Presse Med; 1977 Nov; 6(38):3550. PubMed ID: 202922
    [No Abstract]   [Full Text] [Related]  

  • 22. [Peripheral neuropathy after perhexilene maleate administration].
    Nicolas G; Delobel R; Feve JR; Rozo L
    Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):607-10. PubMed ID: 188361
    [No Abstract]   [Full Text] [Related]  

  • 23. [Letter: Perhexiline maleate and lipid metabolism disorders].
    Crevelier A; Duplay H
    Nouv Presse Med; 1974 Oct; 3(34):2182-3. PubMed ID: 4438069
    [No Abstract]   [Full Text] [Related]  

  • 24. Electromyographic findings and conduction velocity on N-hexane polyneuropathy.
    Iida M; Yamamura Y; Sobue I
    Electromyography; 1969; 9(3):247-61. PubMed ID: 4313481
    [No Abstract]   [Full Text] [Related]  

  • 25. Polyneuropathy after perhexiline maleate therapy.
    Lhermitte F; Fardeau M; Chedru F; Mallecourt J
    Br Med J; 1976 May; 1(6020):1256. PubMed ID: 178402
    [No Abstract]   [Full Text] [Related]  

  • 26. Peripheral-nerve lipid abnormalities in patients on perhexiline maleate.
    Pollet S; Hauw JJ; Escourolle R; Baumann N
    Lancet; 1977 Jun; 1(8024):1258. PubMed ID: 68353
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neurological disorders and perhexiline maleate therapy. Clinical study of 10 cases. Neuropathological, pharmacocinetic and biochemical studies (author's transl)].
    Nick J; Dudognon P; Escourolle R; Bakouche P; Nicolle MH; Reignier A; Hauw JJ; Ermidou S; Pollet S; Baumann N; Singlas E; Lévy J
    Rev Neurol (Paris); 1978 Feb; 134(2):103-14. PubMed ID: 211569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Electrological aspect of infraclinical neuropathies in the course of alcoholism].
    de Bisschop G; Atlan D; Roger J; Giraud J; Fressy J; Dumoulin J
    Mars Med; 1972; 109(9):549-51. PubMed ID: 4344782
    [No Abstract]   [Full Text] [Related]  

  • 29. [Oedematous optic neuropathy from Perhexilline maleate associated with peripheral polyneuropathy (author's transl)].
    van Effenterre R; Poisson M; van Effenterre G; Schaison M; Sichez JP; Haut J
    Arch Ophtalmol (Paris); 1977; 37(11):709-14. PubMed ID: 205202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical applications of the estimation of nerve conduction velocity distributions.
    Sax DS; Kovacs ZL; Johnson TL; Feldman RG
    Prog Clin Biol Res; 1981; 52():113-36. PubMed ID: 6262836
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous silent period (CSP) in peripheral neuropathies represents the temporary suppression of the intentional electromyographic activities.
    Francia A; Restante R; Mistura L; Fabri P; Mamarella A; Pennisi E; Manfredi M
    J Peripher Nerv Syst; 1999; 4(1):86. PubMed ID: 10197067
    [No Abstract]   [Full Text] [Related]  

  • 32. Investigations of long-term treatment with perhexiline maleate using therapeutic monitoring and electromyography.
    Pilcher J; Cooper JD; Turnell DC; Matenga J; Paul R; Lockhart JD
    Ther Drug Monit; 1985; 7(1):54-60. PubMed ID: 3992623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral neuropathy due to perhexilene maleate.
    Wijesekera JC; Critchley EM; Fahim Y; Lynch PG; Wright JS
    J Neurol Sci; 1980 Jun; 46(3):303-9. PubMed ID: 6247455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myopathy caused by perhexiline maleate].
    Gil Néciga E; Bautista J
    Neurologia; 1987; 2(2):86-7. PubMed ID: 3274074
    [No Abstract]   [Full Text] [Related]  

  • 35. Muscle and nerve changes induced by perhexiline maleate in man and mice.
    Fardeau M; Tomé FM; Simon P
    Muscle Nerve; 1979; 2(1):24-36. PubMed ID: 232538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypoglycemia in 2 patients treated with perhexiline maleate].
    Dally S; Lagier G; Assan R; Gaultier M
    Nouv Presse Med; 1977 May; 6(19):1643-4, 1649. PubMed ID: 866152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible conduction block in human ischemic neuropathy after ergotamine abuse.
    Hömberg V; Reiners K; Toyka KV
    Muscle Nerve; 1992 Apr; 15(4):467-70. PubMed ID: 1314328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of perhexiline maleate neurotoxicosis.
    Myers JB
    Med J Aust; 1979 Oct; 2(8):422. PubMed ID: 318475
    [No Abstract]   [Full Text] [Related]  

  • 39. Cirrhosis of the liver following therapy with perhexiline maleate.
    Hay DR; Gwynne JF
    N Z Med J; 1983 Mar; 96(728):202-4. PubMed ID: 6572824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoniazid induced neuropathy in slow versus rapid acetylators: an electrophysiological study.
    Goel UC; Bajaj S; Gupta OP; Dwivedi NC; Dubey AL
    J Assoc Physicians India; 1992 Oct; 40(10):671-2. PubMed ID: 1339149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.